Tumor Stem Articles & Analysis
10 news found
The range of PC basic research services includes PC pathology research, PC cell research, PC stem cell research, PC tumor model, and more. At the same time, Alfa Cytology can also offer drug development services for pancreatic cancer with the data obtained from PC basic research. ...
Crown Bioscience, a JSR Life Sciences company, and HUB Organoids (HUB) announced today the publication of preclinical data in the journal, Nature Cancer, on a bispecific antibody which prevents the onset of metastasis and slows the growth of primary tumors in experimental models of cancer. The study was the result of work by an international consortium, SuppresSTEM which ...
PHILADELPHIA, March 08, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that five abstracts have been selected for poster or symposium presentations at the American Association for ...
IRVINE, Calif. – Oct. 29, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced the publication of the peer-reviewed manuscript, “Co-grafts of Human Stem Cell-Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons Rats,” ...
” About ParvOryx ParvOryx (Parvovirus H1) is a wild type rat oncolytic virus that infects and lyses tumor cells in a wide variety of cancers, including glioblastoma multiforme, pancreatic cancer, breast cancer, lung cancer, melanoma, lymphoma, pediatric tumors such as neuroblastoma and medulloblastoma, prostate cancer and renal cancer, as well as ...
The combination treatment was well tolerated by all patients and led to objective tumor response and significantly prolonged survival times. On the basis of compelling safety, tolerability and efficacy data stemming from both the rGBM trial and from the follow-up program, ORYX requested meetings with the regulatory authorities both in the EU and US to discuss ...
Secondary endpoints included anti-tumor effects and cellular immune response, plus overall survival. To identify immunological and molecular signatures of responses, three serial liver biopsies (before, during, and after virotherapy) allowed for in-depth analyses of pathological tumor characteristics, tumor-infiltrating immune cells, ...
On Sunday, 3rd July, Mike Callaghan – Head of Business Development at GPT Waste Management Ltd completed the Windermere Triathlon in a bid to raise funds for The Joshua Wilson Brain Tumour Charity. The Windermere Triathlon is in no way for the faint hearted. It is a challenge only undertaken by those strong enough, and brave enough to believe they can reach the finish line. Starting with ...
They are using a combination of genomic and proteomic technologies from Agilent to characterize tumor-initiating cells with stem-cell-like properties derived from solid tumors taken from subjects with various types of cancer. ...
Researchers at the National Institutes of Health have discovered how exposure to arsenic can turn normal stem cells into cancer stem cells and spur tumor growth. Inorganic arsenic, which affects the drinking water of millions of people worldwide, has been previously shown to be a human carcinogen. ...